Company / Operating Margin
Innoviva, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
39.8%
FY2025
5-year range
36.7% / 95.7%
FY2021-FY2025
Trend
-14.4%
vs FY2024
Sector context
#9 of 135
Health Care
What the data says
Among 135 Health Care companies, Innoviva, Inc. is in the top 7% for operating margin. Operating Margin has fluctuated over the past 9 years, ranging from 36.7% in FY2023 to 453.4% in FY2017.
Based on SEC 10-K filings.
39.8% in FY2025 with a 5-year CAGR of -55.5%. Top quartile in the Health Care sector.
Improved from 36.7% to 39.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -55.5pp
- 10-Year Change
- -
Sector benchmark
Top 7% in Health CareTop 7% of 135This company 39.8% Sector average -774.4%
▼
+105.1% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 14.4% year-over-year.
- Currently 814.3pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 39.8% | -14.4% |
| FY2024 | 46.5% | +26.8% |
| FY2023 | 36.7% | - |
| FY2022 | - | - |
| FY2021 | 95.7% | +0.4% |
| FY2020 | 95.3% | +12.8% |
| FY2019 | 84.5% | +3.6% |
| FY2018 | 81.6% | -82.0% |
| FY2017 | 453.4% | +455.7% |
| FY2016 | 81.6% | +39.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026